<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03885583</url>
  </required_header>
  <id_info>
    <org_study_id>aunanesth202019</org_study_id>
    <nct_id>NCT03885583</nct_id>
  </id_info>
  <brief_title>Post-operative Pulmonary Function After Thoracotomy Under Two Different Techniques</brief_title>
  <official_title>Evaluation of Post-operative Pulmonary Function After Open Thoracotomy: Comparison Between Thoracic Epidural and Paravertebral Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the respiratory and analgesic effects of continuous thoracic paravertebral block
      versus thoracic epidural in patients undergoing thoracotomy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study tools

        -  An Ultrasound machine (Madison X6) with superficial linear and curved probe.

        -  A 19 gauge echogenic needle and Plexolong Cather (PAJUNK, Plexolong Meier nanoline,
           Geisingen, Germany; 60 mm).

        -  A 17-gauge Tuohy needle and 19 G flex-tip catheter: for thoracic epidural.

        -  Spirometer: (Enraf-Nonius, Model SPIRO 601).

        -  Drugs: isobaric bupivacaine 0.25% (aside from the drugs used in the standard operation
           theatre).

        -  Computer software: computer generated random tables (for randomization) and SPSS 22 (for
           data analysis)

      Thoracic epidural (TEP):

      A pre-procedural ultrasound examination will be done to first identify the correct targeted
      thoracic level. To accomplish this, the transducer will be placed in the parasagittal plane
      approximately 5 cm from midline. The thoracic level will be determined by identifying the
      12th rib and counting in a cephalad direction until the targeted level is marked.

      All epidurals will be performed under all aseptic precautions with a 17-gauge Tuohy needle
      and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheters will
      be inserted 4 cm into the epidural space and a suitable test dose will be administered to
      exclude intravascular or sub-arachnoid injection

      Bupivacaine 0.25% of 7.5-12 ml volume will be given through the epidural catheter then
      continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h
      with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain. The block
      height will be tested using pin prick method. After spirometry testing and diaphragmatic
      ultrasound, the infusion of TEP will be gradually weaned of and the catheter will be removed
      under complete aseptic precautions.

      Thoracic paravertebral block: (TPVB) The Ultrasound-probe will be centered on T7. The
      sagittal technique at the transverse process, in-plane, will be used. The 19 gauge echogenic
      needle will be inserted in-plane at the lower border of the transducer and advanced in a
      cephalad position with real-time ultrasound sonography.

      Injection of small amounts of fluid (hydro-dissection) will aid in needle tip location. When
      the needle tip reaches the paravertebral space, 7.5-12 ml Bupivacaine 0.25% will be slowly
      injected after negative aspiration. The endpoint for a successful block is anterior
      displacement of the pleura. The catheter will be then inserted through the needle and
      positioned up to 3 cm from skin entry directing upwards in the paravertebral space then
      continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h
      with bolus infusion of 5 to 10 ml of the infusion mixture for breakthrough pain.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vital capacity</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>forced vital capacity</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Technologies)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>forced expiratory volume in one second</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>measured by spirometer (Enraf-Nonius, Model SPIRO 601 medical Tecnologies)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>pain will be assessed using VAS score, it provides a range of scores from 0-100. A higher score indicates greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragmatic excursion</measure>
    <time_frame>24 hours after operation</time_frame>
    <description>ultrasound assessment of diaphragmatic excursion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pulmonary Function</condition>
  <arm_group>
    <arm_group_label>thoracic epidural group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group will receive ultrasound guided thoracic epidural block preoperatively for pain management, continuous infusion of 0.5% bupivacaine through epidural catheter during operation and early post-operative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paravertebral group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients in this group will receive ultrasound guided pararvertebral block preoperatively for pain management, continuous infusion of paravertebral bupivacaine 0.5% through paravetebral catheter during operation and early post-operative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracic epidural block</intervention_name>
    <description>thoracic epidural block with bupivacaine 0.25% will be given in the 8th thoracic space using ultrasound</description>
    <arm_group_label>thoracic epidural group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paravertebral block</intervention_name>
    <description>paravertebral block with 0.25 bupivacaine will be given at the level of the incision using ultrasound</description>
    <arm_group_label>paravertebral group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA II, III

          -  elective thoracotomy surgery

        Exclusion Criteria:

          -  patient refusal

          -  contraindications to neuraxial blocks

          -  pneumonectomy

          -  planed postoperative mechanical ventilatoin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed G Abdelraheem, MD</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Khaled A Abdelrahman, MD</last_name>
    <phone>00200882413201</phone>
    <email>khbaqy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Hamdy A Youssef, MD</last_name>
      <phone>00208824132.4</phone>
      <email>hamdyayoussef@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2019</study_first_posted>
  <last_update_submitted>March 21, 2019</last_update_submitted>
  <last_update_submitted_qc>March 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Khaled Abdelbaky Abdelrahman</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>thoracotomy</keyword>
  <keyword>thoracic epidural block</keyword>
  <keyword>paravertebral block</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

